Rivercell
PrivateLast Round
Seed
Oct 7, 2026
Total Funding Raised
$25M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Rivercell operates in Healthcare & Life Sciences and is based in Paris. Its latest recorded funding round was a Seed round in October 2026.
Rivercell is a biotechnology and AI company that develops proprietary cell-response data infrastructure and a world model to predict how human cells respond to treatments.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Synthetic Data
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Foundation
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Rivercell Comparables
Compare Rivercell with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Bioptimus | 86% | |
| Standard Model Biomedicine | 86% | |
| GenBio AI | 86% |
For institutional investors. Book with your work email.
Rivercell Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Rivercell Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| HV Capital | Seed |
| Alven | Seed |
| HCVC | Seed |
| Bpifrance Digital Venture | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 7, 2026
$25M round led by HV Capital.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- hiresOct 7, 2026
Rivercell adds Fabian Theis, director of the Computational Health Center at Helmholtz Munich, to its scientific advisory board alongside Charlotte Bunne, an assistant professor of artificial intelligence in molecular medicine at EPFL.
- expands_facilitiesOct 7, 2026
A $25 million financing supports Rivercell's planned expansion of its automated wet lab in Paris on Oct 7th '26.
- launchesOct 7, 2026
Rivercell plans to launch its AI Virtual Cell programme as a €22 million Seed investment supports its data-generation platform and Paris wet-lab expansion.
- receives_financingOct 7, 2026
On Oct 7th '26, Rivercell receives a $25M (€22 million) Seed round led by HV, with participation from HCVC, Alven and Bpifrance Digital Venture, to scale its proprietary data platform, expand its Paris wet lab and launch its AI Virtual Cell program.
For institutional investors. Book with your work email.
Rivercell Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Rivercell's valuation, stock price, and market status.
Is Rivercell a public or private company?
Rivercell is a private company.
What is the current stock price of Rivercell?
Rivercell is a private company, so its shares have no public market price. Caplight tracks Rivercell's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Rivercell worth (valuation)?
Valuation information for Rivercell is not publicly available.
Can I buy Rivercell stock?
Rivercell shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Rivercell's last funding round?
Rivercell's most recent funding round was Seed on October 7, 2026.
Who are the main investors in Rivercell?
Key investors in Rivercell include HV Capital.
Will Rivercell IPO soon?
No public IPO plans have been announced for Rivercell.
How can I track Rivercell secondary market activity?
Caplight tracks bids, offers, and trades in Rivercell's shares on secondary markets.